Connect with us

Hi, what are you looking for?

Investing

Adrian Day: US$2,500 Gold? Pullback Would be “Healthy,” Reasons to Buy Remain

The gold price has seen ups and downs since the US election.

The yellow metal took a hit directly after Donald Trump’s victory, falling to the US$2,550 per ounce level. But then it staged a quick recovery, passing US$2,700. It’s now pulled back again, currently at around US$2,650.

In his view, a fall to US$2,500 wouldn’t be surprising in that scenario.

‘But I would say to anyone — certainly if they’re not invested in gold — don’t wait for that. The key is that the reasons to buy gold have not changed, and we still need gold for a lot of reasons,’ Day said.

‘Gold is not a political metal. Gold to me is the anti-fiat metal, if you want,’ he explained.

‘And obviously a strong dollar — strong against other currencies — is negative for gold. But you can have a strong dollar and still be losing purchasing power. The dollar’s lost 22 percent of its purchasing power in the last four years — that’s by the government’s own numbers. So that in itself tells you … you need it. You need gold,’ Day added.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

World biggest companies

Learn Trading With Online Courses, Classes, & Lessons

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 GreatWallStreetPublisher.com